Thriving Through Transitions in JIA Care: The Vital Role of Advanced Practice Providers

Juvenile idiopathic arthritis (JIA) is an arthritis of unknown origin that affects approximately 300,000 children and teens in the United States. JIA has a serious impact on quality of life and can continue into adulthood in some patients. The diagnosis of JIA is challenging, as it is a diagnosis of exclusion and can easily be missed, often leading to a delay in treatment. The management of JIA involves a multidisciplinary team that typically includes a rheumatologist; however, an ongoing and increasing shortage of rheumatology professionals necessitates the involvement of advanced practice providers—including PAs and NPs—in the management and transitioning of care from pediatric to adult care settings. The current state of care is evolving with new therapies and emerging guidelines, and clinicians who manage patients with JIA must remain up to date on available therapies and treatment recommendations. In this interactive activity, expert faculty discuss the etiology and classification of Juvenile Idiopathic Arthritis (JIA) as well as cases that will help clinicians diagnose, classify, and optimally threat their patients with JIA.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Describe the clinical presentation and diagnosis of JIA
  • Evaluate the efficacy, safety, and role of DMARDs in the management of JIA, including new treatments and guidelines
  • Discuss the importance of appropriate transition from pediatric to adult care

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Pfizer.